Centessa Pharmaceuticals Ownership | Who Owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals Ownership Summary
Centessa Pharmaceuticals is owned by 27.05% institutional investors, 0.47% insiders, and 72.48% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 14.71% of CNTA shares. American Funds SMALLCAP World A is the top mutual fund, with 2.86% of its assets in Centessa Pharmaceuticals shares.
CNTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Centessa Pharmaceuticals | 27.05% | 0.47% | 72.48% |
| Sector | Healthcare Stocks | 35.74% | 11.83% | 52.43% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 19.96M | 14.71% | $792.94M |
| Avoro capital advisors | 11.43M | 8.42% | $454.02M |
| Index venture life associates vi | 9.96M | 7.34% | $395.68M |
| Adage capital partners gp | 8.93M | 6.58% | $354.50M |
| Pentwater capital management lp | 8.17M | 6.02% | $324.51M |
| Fmr | 6.85M | 5.05% | $272.16M |
| Ecor1 capital | 6.00M | 4.42% | $238.32M |
| Perceptive advisors | 5.26M | 3.87% | $208.88M |
| Capital world investors | 4.83M | 3.56% | $191.95M |
| Farallon capital management | 4.81M | 3.54% | $191.01M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Index venture life associates vi | 9.96M | 100.00% | $395.68M |
| Medicxi ventures management (jersey) | 19.96M | 80.76% | $792.94M |
| Foresite capital management vi | 1.36M | 11.77% | $54.18M |
| Ecor1 capital | 6.00M | 10.11% | $238.32M |
| Allostery investments lp | 52.50K | 8.79% | $689.85K |
| 5am venture management | 580.95K | 6.41% | $23.08M |
| First light asset management | 1.56M | 5.56% | $62.00M |
| Tcg crossover management | 4.29M | 4.87% | $170.26M |
| Avoro capital advisors | 11.43M | 4.47% | $454.02M |
| Logos global management lp | 2.13M | 4.21% | $84.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pentwater capital management lp | 8.17M | 1.68% | 8.17M |
| Capital world investors | 4.83M | 0.03% | 3.67M |
| Paradigm biocapital advisors lp | 3.57M | 2.90% | 3.57M |
| Morgan stanley | 4.27M | 0.01% | 3.16M |
| Ecor1 capital | 6.00M | 10.11% | 2.88M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| General atlantic | 1.35M | 2.50% | -4.76M |
| Vida ventures advisors | - | - | -3.93M |
| Price t rowe associates inc /md/ | - | - | -3.93M |
| Avoro capital advisors | 11.43M | 4.47% | -3.13M |
| Siren | 1.05M | 1.16% | -2.97M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Pentwater capital management lp | 8.17M | 1.68% | 8.17M | $324.51M |
| Paradigm biocapital advisors lp | 3.57M | 2.90% | 3.57M | $141.96M |
| Alpine associates management | 865.50K | 2.03% | 865.50K | $34.38M |
| Bnp paribas asset management | 702.25K | 0.03% | 702.25K | $27.89M |
| Eventide asset management | 668.14K | 0.44% | 668.14K | $26.54M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -17.00 |
| Bell investment advisors | -31.00 |
| Caldwell sutter capital | -43.00 |
| Spire wealth management | -70.00 |
| Bellevue asset management | -70.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 75 | -52.23% | 36,717,251 | -74.46% | 27 | 0.24% | 49 | -43.02% | 17 | -66.00% |
| Dec 31, 2025 | 103 | -26.95% | 89,972,752 | -29.89% | 67 | 0.73% | 56 | -11.11% | 32 | -36.00% |
| Sep 30, 2025 | 140 | 10.24% | 128,318,654 | 3.84% | 95 | 1.11% | 62 | -11.43% | 50 | 47.06% |
| Jun 30, 2025 | 126 | -10.00% | 123,550,297 | -0.00% | 92 | 1.08% | 69 | -9.21% | 34 | -8.11% |
| Mar 31, 2025 | 141 | 18.49% | 124,864,870 | 0.36% | 93 | 0.82% | 75 | 22.95% | 38 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 4.42M | 2.86% | 3.29M |
| Fidelity Select Biotechnology | 2.15M | 1.39% | -39.80K |
| T. Rowe Price Health Sciences | 1.89M | 1.28% | -300.66K |
| Fidelity Select Health Care | 1.65M | 1.07% | - |
| Fidelity Contrafund | 1.32M | 0.85% | 88.15K |
| Federated Hermes Kaufmann R | 1.24M | 0.80% | - |
| Federated Hermes Kaufmann Growth | 1.24M | 0.80% | - |
| Polar Capital Biotech S Inc | 1.00M | 0.75% | - |
| Janus Henderson US SMID Cap Growth MA | 953.94K | 0.71% | 953.86K |
| Franklin Biotechnology Discv A(acc)USD | 1.06M | 0.69% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Medicxi Ventures Management (Jersey) Ltd | - | Sell | $10.68M |
| Jun 24, 2026 | INDEX VENTURES LIFE VI (JERSEY) L.P. | - | Sell | $5.68M |
| Mar 26, 2026 | Anderson Karen M. | Chief People Officer | Sell | $1.24M |
| Mar 26, 2026 | Weinhoff Gregory M | Chief Business Officer | Sell | $719.94K |
| Mar 17, 2026 | Anderson Karen M. | Chief People Officer | Sell | $282.21K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2026 Q1 | - | 10 |
| 2025 Q4 | - | 8 |
| 2025 Q3 | - | 14 |
| 2025 Q2 | 2 | 12 |
CNTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools